Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol
- PMID: 19664210
- PMCID: PMC2746190
- DOI: 10.1186/1471-2431-9-49
Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol
Abstract
Background: Reference values for hematological and biochemical assays in pregnant women and in newborn infants are based primarily on Caucasian populations. Normative data are limited for populations in sub-Saharan Africa, especially comparing women with and without HIV infection, and comparing infants with and without HIV infection or HIV exposure.
Methods: We determined HIV status and selected hematological and biochemical measurements in women at 20-24 weeks and at 36 weeks gestation, and in infants at birth and 4-6 weeks of age. All were recruited within a randomized clinical trial of antibiotics to prevent chorioamnionitis-associated mother-to-child transmission of HIV (HPTN024). We report nearly complete laboratory data on 2,292 HIV-infected and 367 HIV-uninfected pregnant African women who were representative of the public clinics from which the women were recruited. Nearly all the HIV-infected mothers received nevirapine prophylaxis at the time of labor, as did their infants after birth (always within 72 hours of birth, but typically within just a few hours at the four study sites in Malawi (2 sites), Tanzania, and Zambia.
Results: HIV-infected pregnant women had lower red blood cell counts, hemoglobin, hematocrit, and white blood cell counts than HIV-uninfected women. Platelet and monocyte counts were higher among HIV-infected women at both time points. At the 4-6-week visit, HIV-infected infants had lower hemoglobin, hematocrit and white blood cell counts than uninfected infants. Platelet counts were lower in HIV-infected infants than HIV-uninfected infants, both at birth and at 4-6 weeks of age. At 4-6 weeks, HIV-infected infants had higher alanine aminotransferase measures than uninfected infants.
Conclusion: Normative data in pregnant African women and their newborn infants are needed to guide the large-scale HIV care and treatment programs being scaled up throughout the continent. These laboratory measures will help interpret clinical data and assist in patient monitoring in a sub-Saharan Africa context.
Trial registration: ClinicalTrials.gov NCT00021671.
Figures
References
-
- Beers MH, Porter RS, Jones TV, Kaplan JL, Berkwits M. Approach to the patient with anemia: Hematology and Oncologyin the Merck Manual of Diagnosis and Therapy. 18. Chapter 3. Merck Research Laboratories, Division of Merck & Co., Inc. Whitehouse Station NJ; 2006. pp. 1031–1033.
-
- Mukiibi JM, Mtimavalye LAR, Broadhead R, et al. Some hematological parameters in Malawian neonates. East Afr Med J. 1995;72:10–14. - PubMed
-
- Miller MF, Stoltzfus RJ, Iliff PJ, et al. Effect of maternal and neonatal vitamin A supplementation and other postnatal factors on anemia in Zimbabwean infants: a prospective, randomized study. Am J Clin Nutr. 2006;84:212–222. - PubMed
-
- Fleming AF, Harrison KA. Leukocyte counts during pregnancy and the puerperium and at birth in Nigerians. East Afr Med J. 1985;62:175–184. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- U01 AI068619/AI/NIAID NIH HHS/United States
- N01 AI045200/AI/NIAID NIH HHS/United States
- N01 AI035173/AI/NIAID NIH HHS/United States
- U01-AI-048006/AI/NIAID NIH HHS/United States
- U01 AI048006/AI/NIAID NIH HHS/United States
- N01-AI-035173-117/412/AI/NIAID NIH HHS/United States
- U01 AI048005/AI/NIAID NIH HHS/United States
- U01-AI-047972/AI/NIAID NIH HHS/United States
- U01 AI047972/AI/NIAID NIH HHS/United States
- U01-AI-068619/AI/NIAID NIH HHS/United States
- N01-AI-035173/AI/NIAID NIH HHS/United States
- U01-AI-048005/AI/NIAID NIH HHS/United States
- N01-AI-045200/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
